Skip to content

Levobupivacaine

  • Prescription medicine
  • Varies by country
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Levobupivacaine does in the body

RNAWiki has not recorded what this substance changes in the body.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Professional supervision is normally required. It is a prescription or clinician-administered medicine where it is approved.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · A5H73K9U3W · read 2026-08-29

  • Its recorded molecular formula is C18H28N2O, weighing 288.4.

    PubChem record · 92253 · read 2026-08-29

Where each sentence above came from

No plain explanation of what this changes is stored.

No recorded use is stored in reader language.

No statement of the main limit is recorded.

The four opening statements run to 26 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Placebo

A placebo is a dummy treatment given so the real one can be compared with it.

A picture of it, and where the picture fails

A placebo is like a blank control in an experiment.

Where that stops being true. A blank does nothing. People given a placebo often do get better.

What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.

An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.

Comparator

A comparator is whatever the treatment was measured against.

A picture of it, and where the picture fails

It is like the other runner in a race.

Where that stops being true. A race has one winner. A study can show both arms improved.

What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.

The control condition against which the experimental intervention is assessed.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Postoperative Acute Kidney Injury

The study did not show it

Who was studied
NCT02726620
How many people
22435
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Rate of post-operative pneumonia in hospital

The study did not show it

Who was studied
NCT01648777
How many people
1502
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Recurrence

The study did not show it

Who was studied
NCT05707169
How many people
800
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Recurrence free survival at 2 years

The study did not show it

Who was studied
NCT07458204
How many people
760
Study design
Phase 2
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

Rate of instrumental delivery

The study did not show it

Who was studied
NCT02710877
How many people
671
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot

consumption of local anesthetic

The study did not show it

Who was studied
NCT03407209
How many people
462
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

No description of who was studied is recorded.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (11)
It was studied for a different goal
The studies measured something else entirely. Nothing in this record points to this reason.
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Varies by country

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No form or route is recorded.

No source is stored against this line.

Who oversees it

Professional supervision is normally required. It is a prescription or clinician-administered medicine where it is approved.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

A register records the withdrawal of an approval.

No source is stored against this line.

What is in the pack

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing is recorded about product quality.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

The exact form studied is not recorded.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 3 products list this as an active ingredient in the United States drug directory. 3 of them contain it and nothing else.

    FDA National Drug Code directory · 66583-0815 · read 2026-08-29

  • They are sold as powder.

    FDA National Drug Code directory · 66583-0815 · read 2026-08-29

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

Self-experiment planning is not offered for a prescription or clinician-supervised medicine, withdrawn medicine. The questions below are for a clinician or pharmacist.

Questions worth asking

  • Which of the trials of Levobupivacaine studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Levobupivacaine are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
A5H73K9U3W
CAS registry number
27262-47-1
PubChem compound
92253
ChEMBL
CHEMBL1201193
ChEBI
6149
WHO international nonproprietary name list entry
7465
RxNorm concept
259453
EMA substance identifier
100000091982
DrugBank
DB01002

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Not passed

    Every public sentence names a source

    The opening statement carries no source: the record holds neither an explanation nor a recorded use.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    A register records the withdrawal of an approval.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

How this medicine reached us

Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.

What the approval register records

  • 1 approved application covers products containing this substance. The earliest was NDA020997, approved 19990805 to PURDUE PHARMA LP.

    Drugs@FDA application register · NDA020997 · read 2026-08-29

  • Marketing status on the register: discontinued.

    Drugs@FDA application register · NDA020997 · read 2026-08-29

  • The earliest marketing start date recorded for a listed product is 20180924.

    FDA National Drug Code directory · 66583-0815 · read 2026-08-29

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

9 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • What was measured, goal by goal — found nothing in the sources checked.
  • How close this is to real life — found nothing in the sources checked.
  • The path through the body — found nothing in the sources checked.
  • Felt, measured, or meaningful — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (6)

126 registered trials of Levobupivacaine — at which phases?


Registered studies posting no result
118 of 126

126 registered studies of Levobupivacaine: 57 phase4, 29 na, 20 phase2, 17 phase3, 7 na or unstated, 4 phase1. CLINICALTRIALS_SNAPSHOT · 2026-09-01

683 with a PubMed record

Show the evidence
  • phase4
    57
  • na
    29
  • phase2
    20
  • phase3
    17
  • na or unstated
    7
  • phase1
    4
8 more recorded rows
  • completed
    83
  • unknown
    27
  • terminated
    8
  • active not recruiting
    2
  • not yet recruiting
    2
  • withdrawn
    2
  • recruiting
    1
  • suspended
    1

recorded 2026-09-01 · last checked 2026-09-04

11 of Levobupivacaine's trials stopped: accrual/recruitment, funding/business, other?


accrual/recruitment (3), funding/business (1) and other (7): Levobupivacaine's stop wording, clustered. CLINICALTRIALS_SNAPSHOT · 2026-09-01

"Terminated prior to its planned completion as anticipated by the protocol)."; 11 of 126 registered studies

Show the evidence

Trial

  • NCT01172197
    terminated; "Terminated prior to its planned completion as anticipated by the protocol)."
  • NCT01994967
    withdrawn; "Another regulatory way was defined."
  • NCT02356640
    terminated; "Poor recruitment"
  • NCT02465008
    suspended; "Not recruiting"
  • NCT02689024
    terminated; "recruitment too slow; intervention was standard care in patients who were not included; acute care pathways changed due to policy regarding hip fracture patients"
  • NCT02710877
    terminated; "Stopped funding by Regional Healthcare System."
5 further recorded trials
  • NCT02728310
    terminated; "Terminated"
  • NCT02728323
    terminated; "Terminated"
  • NCT02796547
    withdrawn; "Lack of human ressources"
  • NCT03456661
    terminated; "The surgical approach has changed."
  • NCT03846102
    terminated; "COVID-19 crisis."

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Levobupivacaine used 5ml Chirocaine — over how long?


Human studies of Levobupivacaine used "5ml Chirocaine". ClinicalTrials.gov · 2026-09-01

19 recorded entries; human; also "2.5ml Chirocaine", "chirocaine 0.5%", "Chirocaine, 0.5%, 10 ml, Abbott"

Show the evidence

human

  • NCT01418183
    5ml Chirocaine
  • NCT01418183
    2.5ml Chirocaine
  • NCT01918917
    chirocaine 0.5%
  • NCT01921361
    Chirocaine, 0.5%, 10 ml, Abbott
  • NCT01960543
    Levobupivacaine 7 mg
  • NCT01960543
    Levobupivacaine 9 mg
13 more recorded rows
  • human NCT02185716
    Levobupivacaine 0.25 %
  • human NCT02185716
    Levobupivacaine 0.5%
  • human NCT02557386
    Levobupivacaine 5 mL
  • human NCT02557386
    Levobupivacaine 10 mL
  • human NCT02557386
    Levobupivacaine 15 mL
  • human NCT02557386
    Levobupivacaine 20 mL
  • human NCT02557386
    Levobupivacaine 25 mL
  • human NCT02557386
    Levobupivacaine 30 mL
  • human NCT02691442
    Levobupivacaine 0.5% + epinephrin 1/200000
  • human NCT03549221
    100 mg Levobupivacaine (0.5%, 20 mL)
  • human NCT03825198
    Levobupivacaine 0,25%
  • human NCT04397484
    0.5% Levobupivacaine
  • human NCT04773301
    Levobupivacaína Altan 7,5 mg/ml solución inyectable y para perfusión E F G

recorded 2026-09-01 · last checked 2026-09-04

Which 73 trials of Levobupivacaine posted no result?


Posted no result
73 of 73 completed trials
Registrations
NCT00552864, NCT00437996, NCT00621907, NCT01106001, NCT01199406 and NCT01858090, and 67 more
Completion dates
oldest 2005-06; newest 2024-06-01
Show the evidence

Trial

  • NCT00552864
    2005-06
  • NCT00437996
    2008-01
  • NCT00621907
    2009-05
  • NCT01106001
    2009-09
  • NCT01199406
    2010-01
  • NCT01858090
    2010-01
14 further recorded trials
  • NCT07285759
    2011-02
  • NCT01675895
    2011-07
  • NCT00830089
    2011-12
  • NCT01184794
    2011-12
  • NCT01921361
    2012-01
  • NCT01929252
    2012-08
  • NCT01918917
    2012-12
  • NCT01974843
    2013-01
  • NCT01989312
    2013-02
  • NCT01991288
    2013-07
  • NCT01602250
    2013-08
  • NCT02725229
    2013-12
  • NCT01701778
    2014-01
  • NCT01938755
    2014-01

At the median, Levobupivacaine's trials enrolled 60.5 people — anything larger?


Median enrolment
60.5
Largest enrolment
22435
Registered trials counted
126

What do 92 spontaneous reports say about Levobupivacaine — and not say?


These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.

Levobupivacaine appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 92 reaction mentions were counted: hypotension 18; mental status changes postoperative 10; metabolic alkalosis 10; unevaluable event 10. FAERS via Open Targets · CHEMBL1200749 · 2026-06-24

Show the evidence
  • hypotension
    18
  • mental status changes postoperative
    10
  • metabolic alkalosis
    10
  • unevaluable event
    10
  • confusion postoperative
    10
  • acute generalised exanthematous pustulosis
    9
4 more recorded rows
  • anaphylactic shock
    7
  • motor dysfunction
    7
  • anaesthetic complication
    6
  • cold sweat
    5

recorded 2026-06-24 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL1200749
PubChem CID
117965
CAS number
27262-48-2
RxCUI
259454
InChIKey
LEBVLXFERQHONN-INIZCTEOSA-N
Also called
LEVOBUPIVACAINE HYDROCHLORIDE, (-)-bupivacaine, Bupivacaine (-)-form, L-bupivacaine, Levobupivacaina, Novabupi, lb, (S)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE, BUPIVACAINE (-)-FORM [MI], LEVOBUPIVACAINE [MART.], LEVOBUPIVACAINE [VANDF], Levobupivacaine [WHO-DD]
Salt form
Bupivacaine (-)-form hydrochloride, Levobupivacaine hcl
Development code
CHIROCAINE
Trade name
Levobupivac
Sources (5)

Sources

ChEMBL 37 — CC BY-SA 3.0 Unported · ClinicalTrials.gov — US Government work · Open Targets 26.06 — CC0 · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 3 required field(s) not terminal: Best-supported result, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 5 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.